Company Profile
INmune Bio Stock Price, News & Analysis
- Ticker:
- INMB
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, INmune Bio is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
1.42 USD (-0.70%)
Close
Last updated: June 23, 2026 at 00:00
37.75M USD
Market cap
Why the stock is moving
INMB is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
INmune Bio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, INmune Bio is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
INmune Bio follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, INmune Bio sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of INmune Bio (INMB)?
INmune Bio (INMB) most recently closed at 1.42 USD, a -0.70% move versus the previous session.
What is the market cap of INmune Bio (INMB)?
INmune Bio currently has a market capitalization of 37.75M USD on BioPharmSignal.
What does INmune Bio do?
INmune Bio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is INMB stock listed?
INmune Bio (INMB) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, INmune Bio is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is INmune?
INmune Bio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is INmune Bio targeting with INmune?
INmune Bio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.